Pharmacovigilance Risk Assessment Committee (PRAC) starts review of ifosfamide containing medicines

The EMA’s safety committee (PRAC) has started a review of medicines containing ifosfamide to examine whether there is a higher risk of encephalopathy with ifosfamide available as a ready-made solution or concentrate for solution vs with the powder form.


European Medicines Agency